Microarray Testing for Cancer Patients
Evaluating Microarray Pharmacogenetic Testing in Cancer Patients
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 120 (estimated)
- Sponsor
- Wake Forest University Health Sciences · Other
This trial is looking for cancer patients who are eligible for specific gene testing. Participants will undergo a test that helps doctors choose the right drugs and doses for their cancer treatment.
You may be able to join if
- I am 18 years or older.
- I have given my written consent to participate.
- I am eligible for single-gene DPYD testing.
- I am currently receiving or will receive a fluoropyrimidine-based chemotherapy.
- I can provide extra buccal swabs if needed for testing.
You may not be able to join if
- I have a history of prior allogeneic hematopoietic cell transplantation.
- I have a history of liver transplantation.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThe purpose of this research is to evaluate the impact of a microarray PGx test on prescribing/dosing of drugs and cancer treatments in patients with cancer who are currently eligible for single-gene DPYD testing.
Loading trial locations…